1/12
Looks like no tags are added yet.
Chronic Kidney/Renal Disease
Associate with hypoproliferative anemia
Caused by inadequate EPO production by damaged kidneys, reduced RBC life span (eryptosis) by uremic toxins
Cannot be assessed just by measuring EPO levels since inappropriately normal or inappropriately elevated EPO level based on the severity of anemia
Administer EPO-stimulating agents as primary treatment for patients, including iron supplement if there’s iron deficiency. Check for iron overload if patient needs transfusion
Morphology includes echinocytes
Diabetes Mellitus
Most common endocrine disorder, type I is insulin deficient, and type II is insulin resistant.
Glycated proteins (glucose-binds to proteins)
impairs hypoxia-inducible factor (response to low oxygen and promote EPO)
impairs erythroid precursors
promote inflammatory signaling
Drugs that target angiotensin-converting enzyme to treat diabetes type 2 also contribute to anemia
Treatment of type-I is iron/B12 supplements. Type-II is regulating glucose level
Anemia of Liver Disease {Morphology}
Associate with alcoholism
Affect hemostasis than CBC since coagulation factors come from the liver
Hepatitis (inflammation) cause anemia of chronic inflammation through INF-γ inhibits RBC production
Folate deficiency affects by alcohol, sideroblastic anemia from iron in alcohol beverage
Morphology includes dimorphic population, decreased reticulocytes, macrocytosis, target cells, stomatocytes, acanthocytes (excess cholesterol).
Use supplement for any deficiencies, treat underlying liver diseases. While hypersplenism and advanced liver disease can still cause issue.

Adrenal Insufficiency
Addison disease that leads to reduced cortisol and aldosterone production due to autoimmune polyglandular syndromes
When combined with other endocrine diseases can cause destruction of glands and subsequent hypofunction.
May develop pernicious anemia from destruction of gastric cells which means absent of intrinsic factor (B12)
Treat by intaking glucocorticoids/corticosteroids
Thyroid Disease
Hyperthyroidism: increased oxygen demand
Excess thyroid hormones (T3 & T4) increase basal metabolic rate → tissue consume more oxygen
Hypothyroidism: decreased oxygen demand
Low thyroid hormones (T3 & T4) decrease basal metabolic rate → less oxygen required so RBC production decrease → mild macrocytic hypoproliferative anemia
Hyperparathyroidism
Excessive release of parathyroid hormone (PTH) that increases blood calcium and decrease phosphate reabsorption
Linked to BM fibrosis but no myelophthisic changes
Renal failure retains phosphate, less vitamin D (less calcium absorption). This stimulates more PTH leading to secondary hyperparathyroidism
PTH is considered uremic toxin, which means it contributes to chronic kidney disease
Treatment includes parathyroidectomy, secondary hyperparathyroidism treats with calcimimetics and vitamin D
Hypogonadism
Low androgen (steroid hormone) level from nonfunctional gonads. While follicle-stimulating hormones, and luteinizing hormones increased
Androgen promote erythropoiesis by increasing EPO, and stimulating the marrow. Promote oxygen delivery by increasing 2,3 BPG
Normocytic-normochromic anemia, and low reticulocytes
Treat by administering exogenous androgens
Myelophthisic Anemia
BM infiltration by malignant cells, marrow replacement by fibrosis (collagen & reticulin)
Associate with leukoerythroblastosis (immature WBC, NRBC, and teardrop cells)
Normocytic-normochromic
Treat by chemotherapy to eradicate malignancies from BM, temporarily worsen anemia so correction of iron/B12, EPO-stimulating, and transfusion may needed

Endocrine Disorders

Viral Infections Anemia
Parvovirus B19 causes chronic anemia and pure red cell aplasia
Epstein-Barr virus causes infectious mononucleosis
Hepatitis contributes to liver-disease anemia
SARS-CoV-2 & COVID-19
Decreased iron levels, hyperferritinemia (increased ferritin level) and increased hepcidin levels
Leads to ferroptosis (iron accumulation promotes ROS that damages RBC membrane), increased inflammation (cytokine storm), direct infection of erythroid precursors
lymphopenia, neutrophilia, and thrombocytopenia. Hypercoagulability, increased D-dimer, and prolonged prothrombin time have also been observed in severe cases
HIV & AIDS
Direct destruction of helper T-lymphocytes, susceptible to pathogens
Anemia associated with HIV and AIDS may be due to inflammation, decreased erythropoiesis, increased erythrophagocytosis, immune response to HIV, and side effects of treatment protocols
Anemia of Prematurity
During the first month, all infants experience decrease in HgB as low as 9 g/dL.
Liver-to-kidney EPO switch (decreased level)
HgF → HgA (right-shift, more oxygen drop off)
Iron availability
Decreased RBC lifespan
Anemia is more severe in premature infants from immature respiratory systems, iatrogenic blood loss (excessive phlebotomy for testing)
Treat with iron & vitamin supplements, EPO-stimulating agents, blood transfusion if hypoxia (body lacked oxygen) occurs